Parathyroid Diseases: Clinical Trials

3 trials for Parathyroid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3
Phase 21Terminated 1

Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism
PCO371, Placebo - Hypoparathyroidism
Phase 1TerminatedChugai Pharmaceutical52020-07-232021-06-11
Serum-Free Thymus Transplantation in DiGeorge Anomaly
Serum Free Thymus Transplantation with Immunosuppression, Serum Free Thymus Transplantation without immunosuppression - DiGeorge Anomaly
Phase 1TerminatedSumitomo Pharma Switzerland GmbH22008-04-012022-04-01
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
Cinacalcet HCl - Secondary Hyperparathyroidism, Hypercalcemia
Phase 1 / Phase 2TerminatedMontefiore Medical Center42007-02-092025-04-29

Narrower conditions

DiGeorge Syndrome (1)  ·  Hypercalcemia (1)  ·  Hyperparathyroidism, Secondary (1)  ·  Hypoparathyroidism (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Thymic aplasia (1)

Broader conditions

Endocrine System Diseases (3)  ·  22q11 Deletion Syndrome (1)  ·  Abnormalities, Multiple (1)  ·  Calcium Metabolism Disorders (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Craniofacial Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heart Defects, Congenital (1)  ·  Heart Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

Cinacalcet (1)  ·  Immunosuppression Therapy (1)  ·  PCO371 (1)

Sponsors

Chugai Pharmaceutical (1)  ·  Montefiore Medical Center (1)  ·  Sumitomo Pharma Switzerland GmbH (1)

Countries

United States (2)  ·  Canada (1)  ·  Hungary (1)

Top investigators

M. Louise Markert, M.D., Ph.D (1)  ·  Maria Coco, MD, MS (1)

NIH funding

K12HD043494 (1), R01AI047040 (1), R01AI054843 (1)